Watson Pharma Private Limited — Dapagliflozin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Dapagliflozin · $1.8M export value · DGFT Verified
Watson Pharma Private Limited is the #7 Indian exporter of Dapagliflozin with $1.8M in export value and 63 verified shipments. Watson Pharma Private Limited holds a 3.7% market share in Dapagliflozin exports across 6 countries. The company exports 14 pharmaceutical products worth $63.4M across 7 therapeutic categories.
Watson Pharma Private Limited — Dapagliflozin Export Profile: Buyers & Destinations
Where Does Watson Pharma Private Limited Export Dapagliflozin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ICELAND | $1.0M | 23 | 61.5% |
| CANADA | $324.3K | 9 | 19.1% |
| ISRAEL | $257.3K | 11 | 15.2% |
| ARGENTINA | $69.8K | 18 | 4.1% |
| IRELAND | $801 | 2 | 0.0% |
| BULGARIA | $21 | 2 | 0.0% |
Watson Pharma Private Limited exports Dapagliflozin to 6 countries. The largest destination is ICELAND accounting for 61.5% of Watson Pharma Private Limited's Dapagliflozin shipments, followed by CANADA (19.1%) and ISRAEL (15.2%). These destinations reflect Watson Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Dapagliflozin from Watson Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| JONAR TRANSPORT | ICELAND | $1.0M | 23 |
| TEVA CANADA LIMITED | CANADA | $324.3K | 9 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | ISRAEL | $257.3K | 11 |
| IVAX ARGENTINA MUNRO | ARGENTINA | $69.5K | 9 |
| PRODIECO LIMITED | IRELAND | $801 | 2 |
| M/S EMILIANO ESCAMES, | ARGENTINA | $184 | 3 |
| IVAX ARGENTINA S.A | ARGENTINA | $106 | 3 |
| TEVA PHARMACEUTICALS | BULGARIA | $21 | 2 |
| IVAX ARGENTINA SA | ARGENTINA | $0 | 1 |
| IVAX ARGENTINA S.A. | ARGENTINA | $0 | 2 |
Watson Pharma Private Limited supplies Dapagliflozin to 10 buyers globally. The largest buyer is JONAR TRANSPORT (ICELAND), followed by TEVA CANADA LIMITED (CANADA) and TEVA PHARMACEUTICAL INDUSTRIES LTD (ISRAEL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Dapagliflozin Export Value and How Much Does Watson Pharma Private Limited Contribute?
India exported $34.4M worth of Dapagliflozin through 5,104 shipments from 254 suppliers to 113 countries, serving 502 buyers globally. Watson Pharma Private Limited contributes $1.8M to this total, accounting for 3.7% of India's Dapagliflozin exports. Watson Pharma Private Limited ships Dapagliflozin to 6 countries through 10 buyers.
What Is the Average Shipment Value for Watson Pharma Private Limited's Dapagliflozin Exports?
Watson Pharma Private Limited's average Dapagliflozin shipment value is $29.3K per consignment, based on 63 shipments totaling $1.8M. The largest destination is ICELAND (61.5% of Watson Pharma Private Limited's Dapagliflozin exports).
How Does Watson Pharma Private Limited Compare to Other Indian Dapagliflozin Exporters?
Watson Pharma Private Limited ranks #7 among 254 Indian Dapagliflozin exporters with a 3.7% market share. The top 3 exporters are MICRO LABS LIMITED ($7.7M), AJANTA PHARMA LIMITED ($5.2M), ALEMBIC PHARMACEUTICALS LIMITED ($4.8M). Watson Pharma Private Limited processed 63 shipments to 6 destination countries.
What Dapagliflozin Formulations Does Watson Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DAPAGLIFLOZIN TABLETS 10MG 10KG BATCHNO. 1123501008 MFG DATE.30.08.2023TBS | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 10KG BATCHNO. 1123501009 MFG DATE.30.08.2023TBS | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 10KG BATCHNO. 1123501165 MFG DATE. 12.10.2023TBS | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 10 KG 10KGBATCH NO. 1124500161 MFG DATE. 08.02.2024 | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 12 KG ( BatchNo.1124501280 Mfg Date. 12.12.2024 Expiry Date.30.11.2026) ( Quantity : 975.194 | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 12 KG ( BatchNo.1124501281 Mfg Date. 12.12.2024 Expiry Date.30.11.2026) ( Quantity : 975.581 | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 12 KG ( BatchNo.1124501282 Mfg Date. 12.12.2024 Expiry Date.30.11.2026) ( Quantity : 967.969 | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 12 KG ( BatchNo.1124501296 Mfg Date. 20.12.2024 Expiry Date.30.11.2026) ( Quantity : 972.481 | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 12 KG ( BatchNo.1124501297 Mfg Date. 20.12.2024 Expiry Date.30.11.2026) ( Quantity : 976.744 | $50.0K | 1 |
| DAPAGLIFLOZIN TABLETS 10MG 12 KG ( BatchNo.1124501298 Mfg Date. 20.12.2024 Expiry Date.30.11.2026) ( Quantity : 987.20 | $50.0K | 1 |
Watson Pharma Private Limited exports 62 distinct Dapagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DAPAGLIFLOZIN TABLETS 10MG 10KG BATCHNO. 1123501008 MFG DA with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Dapagliflozin to Key Markets
What Watson Pharma Private Limited must comply with to export Dapagliflozin to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Watson Pharma Private Limited Compare to Nearest Dapagliflozin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | INVENTIA HEALTHCARE LIMITED | $4.6M | 111 | 11 | $41.3K |
| 5 | CIPLA LIMITED | $3.3M | 96 | 8 | $34.2K |
| 7 | WATSON PHARMA PRIVATE LIMITED ★ | $1.8M | 63 | 6 | $29.3K |
| 6 | MACLEODS PHARMACEUTICALS LTD | $1.7M | 34 | 8 | $50.0K |
| 8 | HETERO LABS LIMITED | $1.2M | 49 | 11 | $24.8K |
Watson Pharma Private Limited ranks #7 among 254 Indian Dapagliflozin exporters. Average shipment value of $29.3K compared to the market average of $135.5K. The closest competitors by value are INVENTIA HEALTHCARE LIMITED and CIPLA LIMITED.
Which Indian Ports Ship Dapagliflozin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,003 | 19.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 791 | 15.5% |
| DELHI AIR CARGO ACC (INDEL4) | 761 | 14.9% |
| DELHI AIR | 612 | 12.0% |
| Bombay Air | 194 | 3.8% |
| BANGALORE ACC (INBLR4) | 189 | 3.7% |
| BANGALORE AIR | 160 | 3.1% |
| NHAVA SHEVA SEA (INNSA1) | 136 | 2.7% |
Geopolitical & Trade Policy Impact on Watson Pharma Private Limited's Dapagliflozin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Watson Pharma. The Israel-Iran conflict has disrupted key shipping routes in the Red Sea, leading to increased freight costs and extended transit times. These disruptions have particularly impacted time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian exporters to strengthen their foothold in the US market. India's pharmaceutical exports to the US surged by 20.4% to approximately $10.5 billion in FY25, despite challenges such as pricing pressures and regulatory scrutiny. (economictimes.indiatimes.com) This growth underscores the potential for companies like Watson Pharma to expand their presence in the US market.
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers Watson Pharma an opportunity to increase its exports to the EU, provided it meets the stringent regulatory standards set by the European Medicines Agency (EMA). (en.wikipedia.org)
Watson Pharma Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with the number of FDA-approved manufacturing sites surpassing those in the US as of 2024. Instances of non-compliance have also decreased, reflecting improved adherence to quality standards. (business-standard.com) For Watson Pharma, maintaining and enhancing compliance with FDA, WHO GMP, and EMA standards is crucial to sustaining and expanding its export markets.
The evolving regulatory environment, including the EU's Falsified Medicines Directive, necessitates robust traceability and anti-counterfeiting measures. Watson Pharma must invest in advanced serialization and tracking systems to ensure compliance and maintain trust with international partners.
About Watson Pharma Private Limited
Watson Pharma Private Limited exports 14 products worth $63.4M. Beyond Dapagliflozin, top products include Gabapentin, Alprazolam, Hydrochlorothiazide, Prednisone, Simvastatin. View the complete Watson Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dapagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dapagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Watson Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 65 individual customs records matching Watson Pharma Private Limited exporting Dapagliflozin, covering 62 formulations to 6 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 502+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dapagliflozin Export Data from Watson Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Watson Pharma Private Limited's Dapagliflozin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Watson Pharma Private Limited
Full Company Profile →
14 products · $63.4M total trade · 7 categories
Dapagliflozin Stats
Company Overview
Top Products by Watson Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Watson Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dapagliflozin. For current shipment-level data, contact TransData Nexus.